DE1192200B - Process for the preparation of A-nor-B homo 6-Oxo ostrenen - Google Patents
Process for the preparation of A-nor-B homo 6-Oxo ostrenenInfo
- Publication number
- DE1192200B DE1192200B DENDAT1192200D DE1192200DA DE1192200B DE 1192200 B DE1192200 B DE 1192200B DE NDAT1192200 D DENDAT1192200 D DE NDAT1192200D DE 1192200D A DE1192200D A DE 1192200DA DE 1192200 B DE1192200 B DE 1192200B
- Authority
- DE
- Germany
- Prior art keywords
- homo
- oxo
- hydroxy
- acyloxy
- estran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 14
- 238000002360 preparation method Methods 0.000 title claims description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 5
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 claims description 3
- 229910001854 alkali hydroxide Inorganic materials 0.000 claims description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 2
- 150000001735 carboxylic acids Chemical class 0.000 claims description 2
- 238000001640 fractional crystallisation Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical compound OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 description 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- YMWBTMBPEHUMBA-FAKHFBMMSA-N [(3r,3as,4s,8as)-3-hydroxy-6,8a-dimethyl-8-oxo-3-propan-2-yl-2,3a,4,5-tetrahydro-1h-azulen-4-yl] (e)-2-methylbut-2-enoate Chemical compound C\C=C(/C)C(=O)O[C@H]1CC(C)=CC(=O)[C@@]2(C)CC[C@@](O)(C(C)C)[C@H]12 YMWBTMBPEHUMBA-FAKHFBMMSA-N 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 230000001548 androgenic effect Effects 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Description
5>5>
BUNDESREPUBLIK DEUTSCHLAND DEUTSCHES Al^ PATENTAMTFEDERAL REPUBLIC OF GERMANY GERMAN AL ^ PATENT OFFICE
Int. Cl.: Int. Cl .:
C07cC07c
co?co?
6-3/äü6-3 / äü
Deutsche Kl.: 12 ο - 25/07 German class: 12 ο - 25/07
Nummer: 1192 200Number: 1192 200
Aktenzeichen: R 32938IV b/12 οFile number: R 32938IV b / 12 ο
Anmeldetag: 18. Juni 1962 Filing date: June 18, 1962
Auslegetag: 6. Mai 1965Opening day: May 6, 1965
Die Erfindung betrifft ein Verfahren zur Herstellung von neuen A-nor-B-homo-6-Oxo-östrenen der allgemeinen Formel IVThe invention relates to a process for the preparation of new A-nor-B-homo-6-oxo-oestrenes of the general formula IV
OROR
IV Verfahren zur Herstellung von
A-nor-B-homo-6-Oxo-östrenenIV Process for the preparation of
A-nor-B-homo-6-oxo-estrenes
worin R ein Wasserstoffatom oder einen niederen Acylrest bedeutet.wherein R is a hydrogen atom or a lower one Means acyl radical.
Das erfindungsgemäße Verfahren zur Herstellung von Verbindungen der allgemeinen Formel IV besteht darin, daß man ein 3,6-Dioxo-17/?-acyloxy-A-nor-B-homo-östran in enolischer Form (I a bzw. I b) durch katalytische Hydrierung in Gegenwart einer organischen Säure bei Raumtemperatur selektiv reduziert, das erhaltene Gemisch aus dem entsprechenden 3 - Oxo - 6ξ - hydroxy - 17/3 - acyloxy-A-nor-B-homo-östran (II) und dem entsprechenden 3f-Hydroxy-6-oxo-17/3- acyloxy- A-nor-B-homoöstran (III) durch fraktionierte Kristallisation und Chromatographie trennt, die letztere Verbindung nach bekannten Methoden, insbesondere durch Erhitzen in methanolischem Alkalihydroxyd dehydratisiert und das erhaltene 6-Oxo-17/Miydroxy-zl3<5>A-nor-B-homo-östren (IV; R = H) gegebenenfalls mit einem funktioneilen Derivat einer niederen organischen Carbonsäure in an sich bekannter Weise verestert.The process according to the invention for the preparation of compounds of the general formula IV consists in that a 3,6-dioxo-17 /? - acyloxy-A-nor-B-homo-oestran in enolic form (I a or I b) is carried out catalytic hydrogenation in the presence of an organic acid at room temperature selectively reduced, the resulting mixture of the corresponding 3 - oxo - 6ξ - hydroxy - 17/3 - acyloxy-A-nor-B-homo-estran (II) and the corresponding 3f-hydroxy -6-oxo-17 / 3- acyloxy-A-nor-B-homoöstran (III) separates by fractional crystallization and chromatography, the latter compound is dehydrated by known methods, in particular by heating in methanolic alkali hydroxide, and the 6-oxo-17 obtained / Miydroxy-zl 3 < 5 > A-nor-B-homo-oestrene (IV; R = H) optionally esterified with a functional derivative of a lower organic carboxylic acid in a manner known per se.
Nach einer bevorzugten Ausfuhrungsform des erfindungsgemäßen Verfahrens wird die katalytische Hydrierung in Gegenwart von Palladium-Kohle und in Essigsäure durchgeführt.According to a preferred embodiment of the process according to the invention, the catalytic Hydrogenation carried out in the presence of palladium-carbon and in acetic acid.
Die neuen erfindungsgemäß erhaltenen Produkte zeichnen sich durch ihre besonderen hormonalen Eigenschaften aus. Sie sind aktiver als die klassischen Stammsteroide, von denen sie sich ableiten, und zeigen weniger gefährliche Nebenwirkungen. So zeigt das 6-Oxo-17/i-hydroxy-J3(51-A-nor-B-homoöstren eine androgene und anabolisierende Wirkung. Die Löslichkeit dieser Verbindungen gestattet auch eine breitere Anwendung. Sie stellen jedoch auch wertvolle Zwischenprodukte zur Herstellung anderer A-nor-B-homo-Steroide nach bekannten chemischen oder mikrobiologischen Verfahren dar.The new products obtained according to the invention are distinguished by their particular hormonal properties. They are more active than the classic stem steroids from which they are derived and show less dangerous side effects. For example, 6-oxo-17 / i-hydroxy-J 3 (51 -A-nor-B-homoestrous has an androgenic and anabolic effect. The solubility of these compounds also allows them to be used more widely. However, they are also valuable intermediates for the production of others A-nor-B-homo-steroids according to known chemical or microbiological processes.
Anmelder:
Roussel-Uclaf, ParisApplicant:
Roussel-Uclaf, Paris
Vertreter:Representative:
Dr. F. Zumstein,Dr. F. Zumstein,
Dipl.-Chem. Dr. rer. nat. E. Assmann undDipl.-Chem. Dr. rer. nat. E. Assmann and
Dipl.-Chem. Dr. R. Koenigsberger,Dipl.-Chem. Dr. R. Koenigsberger,
Patentanwälte, München 2, Bräuhausstr. 4Patent Attorneys, Munich 2, Bräuhausstr. 4th
Als Erfinder benannt:Named as inventor:
Georges Muller, Nogent, Marne;Georges Muller, Nogent, Marne;
Jacques Martel, Bondy, Seine (Frankreich)Jacques Martel, Bondy, Seine (France)
Beanspruchte Priorität:Claimed priority:
Frankreich vom 19. Juni 1961 (865 322)France of June 19, 1961 (865 322)
Die als Nebenprodukte des erfindungsgemäßen Verfahrens anfallenden S-Oxo-of-hydroxy-H/i-acyloxy - A - nor - B - homo - östrane (II) sind wertvolle Zwischen Verbindungen für die Herstellung anderer physiologisch aktiver Produkte, nämlich der A-nor-B-homo-3-Oxo-östrene, die in Patentanmeldung R 32939IVb/12 ο beschrieben sind.The S-oxo-of-hydroxy-H / i-acyloxy obtained as by-products of the process according to the invention - A - nor - B - homo - oestrane (II) are valuable intermediate connections for the production of others physiologically active products, namely the A-nor-B-homo-3-oxo-oestrene, which are described in patent application R 32939IVb / 12 o.
Das folgende Beispiel dient der näheren Erläuterung des Verfahrens nach der Erfindung. Die augenblicklichen Schmelzpunkte wurden auf der Koflerbank bestimmt. Das Schema gibt einen Überblick über die Reaktionsfolge.The following example serves to explain the method according to the invention in more detail. The instant ones Melting points were determined on the Kofler bench. The scheme gives an overview about the reaction sequence.
Herstellung von 6-Oxo-J3|5)-17j8-hydroxy-A-nor-B-homo-östren (IV; R-H)Production of 6-Oxo-J 3 | 5) -17j8-hydroxy-A-nor-B-homo-oestrene (IV; RH)
Stufe A. Katalytische Hydrierung
der enolischen Form von 3,6-Dioxo- 170-acetoxy-A-nor-B-homo-östran
(Ia bzw. Ib; R = COCHe)Stage A. Catalytic hydrogenation
the enolic form of 3,6-dioxo- 170-acetoxy-A-nor-B-homo-estran (Ia or Ib; R = COCHe)
Man löst 2,68 g S.ö-Dioxo-H^-acetoxy-A-nor-B-homo-östran (F. - 168°C), das im Patent 1 161889 beschrieben ist, in 25 ecm Essigsäure, fügt 1,3 g Palladium-Kohle mit 2O°/o Palladium zu und hydriert Stunden bei Raumtemperatur. Man filtriert, fugt ecm Methylenchlorid zu und wäscht bis zur Neutralität mit Wasser. Man trocknet über Magnesiumsulfat und dampft im Vakuum zur Trockne ein.2.68 g of S.ö-dioxo-H ^ -acetoxy-A-nor-B-homo-estran are dissolved (M.p. - 168 ° C), which is disclosed in patent 1 161889 is described, in 25 ecm acetic acid, adds 1.3 g of palladium-carbon with 20% palladium and hydrogenated Hours at room temperature. It is filtered, added ecm methylene chloride and washed until Neutrality with water. It is dried over magnesium sulphate and evaporated to dryness in a vacuum.
50$ 5M/4S5$ 50 5M / 4S5
Man erhält so 2,7 g einer Verbindung, die im wesentlichen aus einem Gemisch von 3-Oxo-6f-hydroxy-17/i-acetoxy-A-nor-B-homo-östran (II; R = COCH3) und Sf-Hydroxy-o-oxo-n^-acetoxy-A-nor-B-homoöstran (III; R = COCH3) besteht.This gives 2.7 g of a compound which consists essentially of a mixture of 3-oxo-6f-hydroxy-17 / i-acetoxy-A-nor-B-homo-oestran (II; R = COCH3) and Sf- Hydroxy-o-oxo-n ^ -acetoxy-A-nor-B-homoöstran (III; R = COCH 3 ).
Man nimmt in 20 ecm Äther auf und läßt die ätherische Lösung bis zur Kristallisation stehen. Nach Absaugen, Waschen mit Äther und Trocknen erhält man 520 mg der kristallisierten Verbindung II (R = COCH3) vom F. = 2000C. [a]i° = -145° (c = 0,5°/o, Chloroform).One takes up in 20 ecm of ether and lets the ethereal solution stand until crystallization. After suction filtration, washing with ether and drying, 520 mg of crystalline compound II (R = COCH 3), mp = 200 0 C. [a] i ° = -145 ° (c = 0.5 ° / o, chloroform) .
Die Verbindung Π (R = COCH3) ist neu.The compound Π (R = COCH 3 ) is new.
Ihre Struktur wird durch die Werte der Infrarotanalyse bestätigt: Das Vorliegen eines Hydroxyls wird durch eine breite Bande bei 3598 bis 3611 cm"1 angezeigt.Its structure is confirmed by the values of infrared analysis: the presence of a hydroxyl is indicated by a broad band at 3598 to 3611 cm " 1 .
Das 3 - Oxo - 6ί - hydroxy - Πβ- acetoxy - A - nor-B-homo-östran (II; R = COCH3) ist in Aceton, Benzol, Chloroform, Alkohol und Äther löslich und in Wasser unlöslich.The 3 - oxo - 6ί - hydroxy - Πβ- acetoxy - A - nor-B-homo-estran (II; R = COCH3) is soluble in acetone, benzene, chloroform, alcohol and ether and insoluble in water.
Analyse: C20H30O4 = 334,44
Berechnet ... C 71,82%, H 9,04%;
gefunden ... C 71,7%, H 9,0%.Analysis: C 20 H 30 O 4 = 334.44
Calculated ... C 71.82%, H 9.04%;
found ... C 71.7%, H 9.0%.
Das 3ξ - Hydroxy - 6 - oxo -17/3 - acetoxy - A - nor-B-homo-östran (III; R = COCH3) wird durch Chromatographie der ätherischen Mutterlaugen des 3 - Oxo - 6ξ - hydroxy -17/?- acetoxy - A - nor - B - homoöstrans (II; R = COCH3) an Aluminiumoxyd in Benzol abgetrennt. Nach Umkristallisieren aus Hexan erhält man 250 mg der kristallisierten Verbindung III (R = COCH3) vom F. = 148°C. [a]l° =- +125° (c = 0,5%, Chloroform).The 3ξ - hydroxy - 6 - oxo -17/3 - acetoxy - A - nor-B-homo-estran (III; R = COCH 3 ) is obtained by chromatography of the ethereal mother liquors of the 3 - oxo - 6ξ - hydroxy -17 /? - acetoxy - A - nor - B - homoöstrans (II; R = COCH3) separated on aluminum oxide in benzene. After recrystallization from hexane, 250 mg of the crystallized compound III (R = COCH 3 ) with a melting point of 148 ° C. are obtained. [a] l ° = - + 125 ° (c = 0.5%, chloroform).
Die Verbindung ΙΠ (R = COCH3) ist neu.The connection ΙΠ (R = COCH3) is new.
Ihre Struktur wird durch die Werte der Infrarotanalyse bestätigt: Anwesenheit eines Hydroxyls, Anwesenheit eines Carbonyls, das bei 1685 cm"1 in Chloroform und bei 1688 cm-1 in Schwefelkohlenstoff absorbiert.Its structure is confirmed by the values of infrared analysis: presence of a hydroxyl, presence of a carbonyl which absorbs at 1685 cm "1 in chloroform and at 1688 cm" 1 in carbon disulfide.
Das 3| - Hydroxy - 6 - oxo -170- acetoxy - A - nor-B-homo-östran (III; R = COCH3) ist in Aceton, Benzol, Chloroform, Alkohol und Äther löslich und in Wasser unlöslich.The 3 | - Hydroxy - 6 - oxo -170- acetoxy - A - nor-B-homo-estran (III; R = COCH3) is soluble in acetone, benzene, chloroform, alcohol and ether and insoluble in water.
Analyse: C20H30O4 = 334,44
Berechnet ... C 71,82%, H 9,04%;
gefunden ... C 72,2%. H 9,0%.Analysis: C20H30O4 = 334.44
Calculated ... C 71.82%, H 9.04%;
found ... C 72.2%. H 9.0%.
Stufe B. Dehydratisierung vonStage B. Dehydration of
Sf-Hydroxy-o-oxo-n^-acetoxy-A-nor-B-homo-östranSf-Hydroxy-o-oxo-n ^ -acetoxy-A-nor-B-homo-estran
(III; R - COCH3)(III; R - COCH 3 )
Man löst 500 mg des in der vorherigen Stufe erhaltenen 3S-Hydroxy-6-oxo- 170-acetoxy- A-nor-B-homo-östrans (III; R = COCH3) in 5 ecm Methanol und 0,5 ecm lOnormaler wäßriger Natronlauge. Man erhitzt 45 Minuten zum Rückfluß, fügt nach Abkühlen 20 ecm Methylenchlorid zu und wäscht mit Wasser. Man trocknet über Magnesiumsulfat und dampft im Vakuum zur Trockne ein. Der Rückstand wird in 25 ecm Methylenchlorid aufgenommen und an 25 g Aluminiumoxyd (Aktivität II bis III nach Brockmann) Chromatographien. Man eluiert zuerst mit Methylenchlorid, dann mit Methylenchlorid, das 2% Methanol enthält. Man erhält beim Eluieren des Chromatogramms mit der Mischung von Methylenchlorid und 2% Methanol ein Harz, das nach Aufnehmen in etwas Äther kristallisiert. Man erhält so nach Absaugen und Trocknen das 6 - Oxo -17β - hydroxy - d3<5> - A - nor - B - homo - östren (IV; R = H) vom F. = 153°C. [a]? = +42° ± 3 (c = 0,5%, Chloroform).500 mg of the 3S-hydroxy-6-oxo-170-acetoxy-A-nor-B-homo-estran (III; R = COCH 3 ) obtained in the previous stage are dissolved in 5 ecm of methanol and 0.5 ecm of 10 normal aqueous Caustic soda. The mixture is heated to reflux for 45 minutes, after cooling, 20 ecm of methylene chloride are added and the mixture is washed with water. It is dried over magnesium sulphate and evaporated to dryness in a vacuum. The residue is taken up in 25 ecm of methylene chloride and chromatographed on 25 g of aluminum oxide (activity II to III according to Brockmann). It is eluted first with methylene chloride, then with methylene chloride containing 2% methanol. When the chromatogram is eluted with a mixture of methylene chloride and 2% methanol, a resin is obtained which crystallizes after being taken up in a little ether. The 6-oxo-7β -hydroxy-d 3 < 5 > -A-nor-B-homo-estrous (IV; R = H) with a temperature of 153 ° C. is thus obtained after suctioning off and drying. [a]? = + 42 ° ± 3 (c = 0.5%, chloroform).
Das Infrarotspektrum zeigt die Anwesenheit einer Bande bei 1670 cm-1, die das Vorliegen einer Carbonylgruppe an einem heptagonalen Ring zeigt, die mit einer Doppelbindung konjugiert ist.The infrared spectrum shows the presence of a band at 1670 cm -1 , which indicates the presence of a carbonyl group on a heptagonal ring that is conjugated with a double bond.
Analyse: Ci8H26O2 =- 274,4Analysis: Ci 8 H 26 O 2 = - 274.4
Berechnet ... C 78,8%, H 9,6%;
gefunden ... C 78,6%, H 9,5%.Calculated ... C 78.8%, H 9.6%;
found ... C 78.6%, H 9.5%.
Das Produkt ist neu.The product is new.
Das in der Stufe B erhaltene 17/3-hydroxylierte Produkt kann nach bekannten Methoden acyliert werden unter Verwendung funktioneller Derivate niederer organischer Carbonsäuren, ζ. B. der Ameisen-, Essig-, Propion-, Butter-, Isobutter-, Valerian-, Isovalerian-, Trimethylessig-, ß-Trimethylpropion-, Capryl-, Cyclopentylessig-, Cyclohexylessig-, Cyclopentylpropion-, Phenylessig-, 2,4-Dinitrobenzoe- oder Phenoxyessigsäure.The 17/3-hydroxylated obtained in stage B Product can be acylated by known methods using functional derivatives lower organic carboxylic acids, ζ. B. the ants, vinegar, propion, butter, isobutter, Valerian, Isovalerian, trimethyl acetic, ß-trimethyl propion, capryl, cyclopentyl acetic, cyclohexyl acetic, cyclopentyl propion, Phenylacetic, 2,4-dinitrobenzoic or phenoxyacetic acid.
Stufe C. Herstellung vonStage C. Manufacture of
6-Oxo-17/3-benzoyIoxy-J;i<5>-A-nor-B-homo-östren 2J (IV; R - COC6H5)6-Oxo-17/3-benzoyIoxy-J ; i < 5 > -A-nor-B-homo-oestren 2J (IV; R - COC 6 H 5 )
Man löst 30 mg des in Stufe B erhaltenen 6-Oxo-1 Iß - hydroxy - Λ3<5> - A - nor - B - homo - östrens (IV; R = H) in 2 ecm wasserfreiem Benzol und 0,6 ecm Pyridin. Man kühlt im Eisbad ab, gibt 0,25 ecm Benzoylchlorid zu und läßt einige Stunden bei Zimmertemperatur stehen. Dann gibt man unter Abkühlen 0,2 ecm Ameisensäure zu, nimmt in Methylenchlorid auf, wäscht mit 1 η-Salzsäure, mit Wasser, mit einer wäßrigen Natriumbicarbonatlösung und dann mit Wasser. Man destilliert zur Trockne und chromatographiert den so erhaltenen Rückstand an Aluminiumoxyd. Durch Eluieren mit Methylenchlorid, das 2% Methanol enthält, isoliert man 6-Oxo-17/?-benzoyloxy-/13<5>-A-nor-B-homo-östren vom F. = 145°C.30 mg of the 6-oxo-1 Iß -hydroxy-Λ 3 < 5 > -A-nor-B-homo-estrous (IV; R = H) obtained in stage B are dissolved in 2 ecm anhydrous benzene and 0.6 ecm Pyridine. It is cooled in an ice bath, 0.25 ecm of benzoyl chloride is added and the mixture is left to stand for a few hours at room temperature. 0.2 ecm of formic acid is then added with cooling, the mixture is taken up in methylene chloride, washed with 1 η hydrochloric acid, with water, with an aqueous sodium bicarbonate solution and then with water. It is distilled to dryness and the residue thus obtained is chromatographed on aluminum oxide. By eluting with methylene chloride, which contains 2% methanol, 6-oxo-17 /? - benzoyloxy- / 1 3 <5 > -A-nor-B-homo-esters with a melting point of 145 ° C. are isolated.
Die Verbindung ist in Wasser unlöslich und in Äther, Aceton, Benzol und Chloroform löslich. Das IR-Spektrum stimmt mit der vorgeschlagenen Struktur überein.The compound is insoluble in water and soluble in ether, acetone, benzene and chloroform. That IR spectrum is consistent with the proposed structure.
Das Produkt wurde in der Literatur bisher noch nicht beschrieben.The product has not yet been described in the literature.
Verfahrensgemäß kann man auch andere Katalysatoren verwenden und die Art der Lösungsmittel und die Reaktionstemperaturen verändern.According to the process, you can also use other catalysts and the type of solvent and change the reaction temperatures.
3535
4545
Claims (2)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1192200B true DE1192200B (en) | 1965-05-06 |
Family
ID=601918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT1192200D Pending DE1192200B (en) | Process for the preparation of A-nor-B homo 6-Oxo ostrenen |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE1192200B (en) |
-
0
- DE DENDAT1192200D patent/DE1192200B/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE946801C (en) | Process for the preparation of pregnan-11 ª‡ -ol-3,20-dione and allopregnan-11 ª‡-ol-3,20-dione | |
| DE1192200B (en) | Process for the preparation of A-nor-B homo 6-Oxo ostrenen | |
| DE1198818B (en) | Process for the production of 2, 3-epithiosteroids | |
| DE1172670B (en) | Process for the preparation of 3-substituted D-homo-18-nor-androst-13 (17a) -en-17-one derivatives | |
| DE2053310C3 (en) | Process for the preparation of 14-anhydrobufalin | |
| DE932795C (en) | Process for the preparation of A8 (9) -7, 11-dioxy compounds of the cyclopentanopolyhydrophenanthrene series | |
| DE2256912C2 (en) | Digoxigenin-3- [2 ', 3'-dideoxy-glycosides], process for their preparation and their use | |
| DE1192201B (en) | Process for the preparation of A-nor-B-homo-3-oxo-oestrenes | |
| DE1668665C (en) | Process for the preparation of 13-alky 1-gona-1,3,5 (10) -trienes. Eliminated from: 1443123 | |
| DE1418945C3 (en) | Process for the preparation of 16 alpha methyl 17alpha hydroxy 20 oxo pregnandenvaten | |
| DE1176794B (en) | Process for the production of Hellebrigenin from Hellebrigenin or drug extracts containing Hellebrin | |
| DE1159955B (en) | Process for the production of levorotatory isodeserpidic acid-lactone and levorotatory isoreserpidic acid-lactone | |
| DE1195308B (en) | Process for the preparation of 6, 17alpha-dimethyl-4, 6-pregnadiene-3, 20-dione | |
| DE1157222B (en) | Process for the preparation of 11ª ‰, 18-oxido-18ªš-methyl steroids | |
| DE1174778B (en) | Process for the preparation of 3, 4-dimethyl -? - oestratrien-1, 17ª ‰ -diol | |
| DE1243191B (en) | Process for the preparation of therapeutically effective, new substituted androstan-16alpha-yl-alkylenecarboxylic acids | |
| DE1059449B (en) | Process for the preparation of steroids effective for adrenal cortex hormones | |
| DE1443123A1 (en) | Process for the preparation of 13-alkyl-gona-1,3,5 (10) -trienes | |
| DE1147578B (en) | Process for the preparation of new therapeutically active 4 '- (17ª ‰ -androstanyl) derivatives of † -valerolactones or the homologous ª † -butyrolactones | |
| DE1008287B (en) | Process for the preparation of androstadienones | |
| DE1037448B (en) | Process for the preparation of 17-alkyl-19-nortestosterones with antihypertensive and progestational effects | |
| DE1279675B (en) | Process for the production of 19-nor-progesterone | |
| DEC0008002MA (en) | ||
| DE1233876B (en) | Process for the production of new dihydro-D-lysergic acid amide derivatives | |
| DE1620063A1 (en) | Process for the preparation of benzoquinolizine derivatives |